Han Ting Ding

3.2k total citations
31 papers, 2.6k citations indexed

About

Han Ting Ding is a scholar working on Immunology and Allergy, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Han Ting Ding has authored 31 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology and Allergy, 10 papers in Immunology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Han Ting Ding's work include Cell Adhesion Molecules Research (18 papers), Atherosclerosis and Cardiovascular Diseases (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Han Ting Ding is often cited by papers focused on Cell Adhesion Molecules Research (18 papers), Atherosclerosis and Cardiovascular Diseases (8 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Han Ting Ding collaborates with scholars based in United States, United Kingdom and China. Han Ting Ding's co-authors include Francis W. Luscinskas, Geoffrey S. Kansas, F W Luscinskas, Thomas F. Tedder, Karen R. Snapp, Andrew H. Lichtman, Michael A. Gimbrone, Mary E. Gerritsen, Raymond T. Camphausen and Jacqueline W. Pierce and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

In The Last Decade

Han Ting Ding

31 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Han Ting Ding United States	19	1.2k	986	784	587	521	31	2.6k
R Pigott United Kingdom	20	1.1k 1.0×	929 0.9×	1.1k 1.3×	334 0.6×	437 0.8×	28	3.0k
Erik Mul Netherlands	34	1.0k 0.9×	1.5k 1.5×	1.0k 1.3×	391 0.7×	324 0.6×	64	3.5k
Ian K. Campbell Australia	28	507 0.4×	1.6k 1.6×	943 1.2×	325 0.6×	833 1.6×	40	3.6k
David M. Lee United States	26	712 0.6×	2.7k 2.7×	905 1.2×	306 0.5×	472 0.9×	32	4.0k
John Stuart United States	29	906 0.8×	1.2k 1.2×	586 0.7×	198 0.3×	484 0.9×	100	3.2k
Anna M. Piccinini United Kingdom	20	473 0.4×	1.2k 1.3×	950 1.2×	150 0.3×	407 0.8×	33	2.9k
Stefan Masure Belgium	26	471 0.4×	582 0.6×	1.0k 1.3×	607 1.0×	701 1.3×	37	2.8k
F Breviario Italy	18	539 0.5×	1.1k 1.2×	1.3k 1.6×	269 0.5×	285 0.5×	23	2.8k
Graham Wells United Kingdom	20	364 0.3×	527 0.5×	806 1.0×	439 0.7×	618 1.2×	26	2.9k
Margaret Lotz United States	20	972 0.8×	673 0.7×	942 1.2×	107 0.2×	407 0.8×	36	2.5k

Countries citing papers authored by Han Ting Ding

Since Specialization

Citations

This map shows the geographic impact of Han Ting Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Ting Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Ting Ding more than expected).

Fields of papers citing papers by Han Ting Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Ting Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Ting Ding. The network helps show where Han Ting Ding may publish in the future.

Co-authorship network of co-authors of Han Ting Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Han Ting Ding. A scholar is included among the top collaborators of Han Ting Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Ting Ding. Han Ting Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Danese, Silvio, Michael E. Rothenberg, Jeremy J. Lim, et al.. (2024). A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 23(8). 1387–1397. 1 indexed citations

Yu, Yanke, Michael E. Rothenberg, Han Ting Ding, et al.. (2023). Population pharmacokinetics and pharmacodynamics of efmarodocokin alfa (IL-22Fc). Journal of Pharmacokinetics and Pharmacodynamics. 51(2). 141–153. 2 indexed citations

Campochiaro, Peter A., Shamika Gune, Mauricio Maia, Han Ting Ding, & Katie F. Maass. (2021). Pharmacokinetic profile of the Port Delivery System with ranibizumab (PDS) in the phase 3 Archway trial. Investigative Ophthalmology & Visual Science. 62(8). 350–350. 5 indexed citations

Cheung, Dorothy, Alice Fong, Han Ting Ding, et al.. (2021). A phase 1, randomized study to evaluate safety, tolerability, and pharmacokinetics of GDC-3280, a potential novel anti-fibrotic small molecule, in healthy subjects. Pulmonary Pharmacology & Therapeutics. 69. 102051–102051. 5 indexed citations

Chan, Phyllis, Han Ting Ding, Bianca M. Liederer, et al.. (2021). Translational and pharmacokinetic‐pharmacodynamic application for the clinical development of GDC‐0334, a novel TRPA1 inhibitor. Clinical and Translational Science. 14(5). 1945–1954. 16 indexed citations

Zhang, Wenhui, Helen E.J. Tyrrell, Han Ting Ding, et al.. (2021). Comparable Pharmacokinetics, Safety, and Tolerability of Etrolizumab Administered by Prefilled Syringe or Autoinjector in a Randomized Trial in Healthy Volunteers. Advances in Therapy. 38(5). 2418–2434. 2 indexed citations

Pan, Lin, et al.. (2017). A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers. Advances in Therapy. 34(9). 2071–2082. 14 indexed citations

Wei, Zhijian, Yang Liu, Jiaxiao Shi, et al.. (2017). Ropivacaine versus levobupivacaine in peripheral nerve block. Medicine. 96(14). e6551–e6551. 18 indexed citations

Lam, Elaine T., S. Gail Eckhardt, Wells A. Messersmith, et al.. (2011). Abstract C18: A phase I study of enavatuzumab (PDL192, ABT-361), a first-in-class human monoclonal antibody targeting TWEAK (tumor necrosis factor-like inducer of apoptosis) receptor, in patients (Pts) with advanced solid tumors.. Molecular Cancer Therapeutics. 10(11_Supplement). C18–C18. 2 indexed citations

10.

Zonder, Jeffrey A., Ann Mohrbacher, Seema Singhal, et al.. (2011). A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced multiple myeloma. Blood. 120(3). 552–559. 277 indexed citations

11.

Lim, Yaw-Chyn, Karen R. Snapp, Geoffrey S. Kansas, et al.. (1998). Important contributions of P-selectin glycoprotein ligand-1-mediated secondary capture to human monocyte adhesion to P-selectin, E-selectin, and TNF-alpha-activated endothelium under flow in vitro.. PubMed. 161(5). 2501–8. 74 indexed citations

12.

Snapp, Karen R., Han Ting Ding, Kristin A. Atkins, et al.. (1998). A Novel P-Selectin Glycoprotein Ligand-1 Monoclonal Antibody Recognizes an Epitope Within the Tyrosine Sulfate Motif of Human PSGL-1 and Blocks Recognition of Both P- and L-Selectin. Blood. 91(1). 154–164. 28 indexed citations

13.

Allport, Jennifer R., Han Ting Ding, Tucker Collins, Mary E. Gerritsen, & Francis W. Luscinskas. (1997). Endothelial-dependent Mechanisms Regulate Leukocyte Transmigration: A Process Involving the Proteasome and Disruption of the Vascular Endothelial–Cadherin Complex at Endothelial Cell-to-Cell Junctions. The Journal of Experimental Medicine. 186(4). 517–527. 154 indexed citations

14.

Allport, Jennifer R., Han Ting Ding, Ann Ager, et al.. (1997). L-selectin shedding does not regulate human neutrophil attachment, rolling, or transmigration across human vascular endothelium in vitro. The Journal of Immunology. 158(9). 4365–4372. 79 indexed citations

15.

Lichtman, Andrew H., Han Ting Ding, Lori Henault, et al.. (1997). CD45RA-RO+ (memory) but not CD45RA+RO- (naive) T cells roll efficiently on E- and P-selectin and vascular cell adhesion molecule-1 under flow. The Journal of Immunology. 158(8). 3640–3650. 53 indexed citations

16.

Pierce, Jacqueline W., Margaret Read, Han Ting Ding, Francis W. Luscinskas, & Teresa Collins. (1996). Salicylates inhibit I kappa B-α phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. The Journal of Immunology. 156(10). 3961–3969. 253 indexed citations

17.

Goetz, Douglas J., Han Ting Ding, William Atkinson, et al.. (1996). A human colon carcinoma cell line exhibits adhesive interactions with P-selectin under fluid flow via a PSGL-1-independent mechanism.. PubMed. 149(5). 1661–73. 42 indexed citations

18.

Luscinskas, Francis W., et al.. (1996). L- and P-selectins, but not CD49d (VLA-4) integrins, mediate monocyte initial attachment to TNF-α-activated vascular endothelium under flow in vitro. The Journal of Immunology. 157(1). 326–335. 136 indexed citations

19.

Luscinskas, F W, Geoffrey S. Kansas, Han Ting Ding, et al.. (1994). Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins.. The Journal of Cell Biology. 125(6). 1417–1427. 340 indexed citations

20.

Luscinskas, Francis W., Jeanne-Marie Kíely, Han Ting Ding, et al.. (1992). In vitro inhibitory effect of IL-8 and other chemoattractants on neutrophil-endothelial adhesive interactions. The Journal of Immunology. 149(6). 2163–2171. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact